Infectious Diseases
News from the FDA/CDC
This is what a flu pandemic looks like
At first glance, activity level appears to equal the pandemic of 2009-2010.
From the Journals
Growing old with HIV: What’s likely, and how can physicians help?
As HIV-infected individuals age, comorbidities will become an increasing challenge.
From the Journals
Reported penicillin allergies hike inpatient costs
Extra inpatient costs may top $4,000, though confirmatory testing doesn’t confirm most reported allergies.
News
FDA approves new combination drug for HIV patients
A new single pill combination drug was approved to treat HIV-1 infections in virologically suppressed adults.
News
FDA approves complete combo tablet for HIV
Symfi Lo was approved as a complete combo tablet for the treatment of HIV in adults and children.
From the Journals
REPROVE: Ceftazidime-avibactam noninferior to meropenem for nosocomial pneumonia
The REPROVE trial demonstrated ceftazidime-avibactam was noninferior to meropenem for nosocomial pneumonia.
From the Journals
HCV screening, care inadequate for young adults who use opioids nonmedically
Nearly a third of young adults with a positive HCV screening were not referred to care.
News from the FDA/CDC
Psychiatric issues common among hepatitis C inpatients
Comorbidities like drug abuse and psychoses present much more often in those with hepatitis C.
News
nPEP for HIV: Updated CDC guidelines available for primary care physicians
To be effective, PEP needs to be initiated within 72 hours of exposure, but many people don’t know about this option.
Latest News
Drug combo indicated for bacterial pneumonia
Ceftazidime/avibactam is the first new option in years for treatment of HABP/VABP caused by Gram-negative bacteria.
News from the FDA/CDC
Hospitals filling as flu season worsens
CDC director: “Hospitalization rate is the highest we’ve seen” through the end of January.